Therapeutic Peptide Granted Orphan Drug Status for Hepatorenal Syndrome
The Company is currently evaluating OCE-205 in a phase 2 trial in adults who have developed hepatorenal syndrome with acute kidney injury.
The Company is currently evaluating OCE-205 in a phase 2 trial in adults who have developed hepatorenal syndrome with acute kidney injury.
In the CRL, the FDA stated that a satisfactory inspection is required before the NDA can be approved.
New data from DOPPS support previous studies finding higher risk for gastrointestinal injury after use of sodium polystyrene sulfonate.
COVID-19 severity at hospital admission predicts complications even in young adults and those without pre-existing health conditions.
Researchers assessed the impact of medical scribes on operations in a pediatric clinic, including the effect on clinician productivity and workflow efficiency.
A past or present diagnosis of inflammatory bowel disease elevates the risk of progression to kidney failure among patients with IgA nephropathy, according to investigators.